Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study

AIMS: Although adjunctive cilostazol to dual antiplatelet therapy can reduce the risks of clinical events after percutaneous coronary intervention (PCI), whether genetic polymorphism can influence the pharmacodynamics of this regimen has not been evaluated. METHODS: One hundred and twenty-seven pati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kim, In-Suk, Jeong, Young-Hoon, Park, Yongwhi, Yoon, Seong-Eun, Kwon, Tae Jung, Park, Jeong Rang, Hwang, Seok-Jae, Koh, Eun-Ha, Kwak, Choong Hwan, Hwang, Jin-Yong, Kim, Sunjoo
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2012
Témata:
Pharmacogenetics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3376439/
https://ncbi.nlm.nih.gov/pubmed/22007612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.04131.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky